New Market Research Report: Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2015 Update

Genomic Health, Inc. (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The company's commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It conducts extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company operates along with its subsidiaries in over 30 countries including the UK, Germany, France, Ireland, Italy, Japan, the Netherlands, Canada, and the US. Genomic Health is headquartered in Redwood City, California, the US.The company strives to offer personalized care for the UK breast cancer patients. To this end, Genomic Health announced the availability of Onco type DX test to the eligible breast cancer patients through the National Health Service (NHS) in England effective April 01, 2015.

Full Report Details at
- http://www.fastmr.com/prod/998571_genomic_health_ghdx_product.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Genomic Health, Inc.
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Genomic Health, Inc. (GHDX) - Financial and Strategic SWOT Analysis Review
- Cepheid (CPHD) - Product Pipeline Analysis, 2015 Update
- Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2015 Update
- Genomic Health, Inc. (GHDX) - Medical Equipment - Deals and Alliances Profile
- Illumina, Inc. (ILMN) - Product Pipeline Analysis, 2015 Update